Patients Treated with Immune Checkpoint Inhibitors Have Better Quality of Life, Moffitt Analysis Shows

Researchers compared self-reported outcomes of patients treated with and without immunotherapy

Moffitt Cancer Center Joins Dana-Farber Cancer Institute to Help Stop Blood Cancer

Health care initiative aims to provide free screening to adults with higher risks for multiple myeloma

Moffitt Researchers Develop Model to Predict Non-Small Cell Lung Cancer Patient Outcomes to Immunotherapy

Model uses radiomic feature associated with low oxygen in tissues combined with clinical parameters

Adoptive Cell Therapy Plus Checkpoint Inhibitors Show Promise in Non-Small Cell Lung Cancer

Moffitt-initiated pilot study finds patients with checkpoint inhibitor resistant tumors are responding to tumor infiltrating lymphocyte treatment

Moffitt Researchers Show Beta-Cutaneous HPV May Be Predictor of Squamous Cell Carcinoma

Study finds this HPV type and UV exposure increase skin cancer risk

Novel Therapy Shows Promise for Lung Cancer Patients with Rare EGFR Mutation

Amivantamab, an EGFR-MET biospecific antibody, has already received Breakthrough Therapy Designation by the FDA

Moffitt Researchers Identify New Relevant Target for PARP Inhibitor Talazoparib

PARP16 is a novel functionally relevant target for talazoparib that enhances anti-cancer effects when drug is used alone or in combination with...

Moffitt Brings Cancer Screenings Back to Pier 60

The July 31 event marks 25 years of Mole Patrol’s free screenings

Moffitt Physician Receives NCI Cancer Clinical Investigator Team Leadership Award

Zeynep Eroglu, M.D., will receive funding to support clinical and research efforts

Moffitt Cancer Center Receives $10 Million from It Works! Founder to Establish Research Center for Rare Blood Cancer

Transformational gift will enhance cutting-edge research and care for multiple myeloma patients

Moffitt Receives $10.2 Million Grant to Develop New Lung Cancer Therapies

Four distinct research projects will investigate common metabolic pathways that can be targeted therapeutically

An Educational Intervention Can Help Vapers Use Their E-Cigarettes to Quit Smoking, Moffitt Study Finds

Researchers say results could help expand the public health potential of e-cigarettes

Moffitt Researchers Develop Non-invasive Approach to Measure Biomarker Levels, Predict Outcomes in Lung Cancer Patients

New data shows computer models based on deep learning of PET/CT images can measure PD-L1 expression

Analyzing the Tumor Microenvironment at the Single Cell Level Sheds Light on Metastatic Melanoma Outcomes, Moffitt Study Shows

Findings may help better direct targeted treatments by identifying patient response in advance of therapy

Moffitt Cancer Center Experts to Present New Clinical Research Data

American Society of Clinical Oncology virtual conference is June 4-8

News Releases